| Literature DB >> 31897387 |
Alessio Paffoni1, Elisabetta Ballabio1, Sabrina Cesana1, Stefania Ferrari2, Hilda Wyssling1, Marco Claudio Bianchi1.
Abstract
BACKGROUND: According to several laboratory protocols and specific conditions, in vitro fertilization (IVF) dishes with culture media can be prepared 24 hr in advance compared to routine protocols. However, it is not clear if this procedure can affect embryological outcomes.Entities:
Keywords: Culture medium; Embryo; Embryology; IVF
Year: 2019 PMID: 31897387 PMCID: PMC6928405
Source DB: PubMed Journal: J Reprod Infertil ISSN: 2228-5482
Baseline characteristics of the selected couples
| 36.3±3.7 | 36.4±3.8 | 0.88 | |
| 23.1±4.7 | 23.2±4.6 | 0.88 | |
| 4.3±2.0 | 4.4±2.3 | 0.75 | |
| 0.61 | |||
| with miscarriage | 17 (22%) | 31 (20%) | |
| with delivery | 3 (4%) | 11 (7%) | |
| 0.65 | |||
| 0 | 45 (59%) | 81 (53%) | |
| 1–2 | 25 (33%) | 59 (39%) | |
| 3–5 | 6 (7%) | 12 (8%) | |
| 7.7±3.0 | 7.1±2.2 | 0.08 | |
| 2.1 (1.3–3.1) | 1.9 (1.0–3.6) | 0.73 | |
| 47 (6–83) | 32 (8–80) | 0.14 | |
| 0.62 | |||
| Female | 15 (20%) | 20 (13%) | |
| Male | 16 (21%) | 35 (23%) | |
| Female – Male | 14 (18%) | 32 (21%) | |
| Unexplained | 31 (41%) | 65 (43%) |
Data is reported as Mean±SD, Median (IQR) or Number (%).BMI: Body Mass Index. IVF: In Vitro Fertilization. FSH: Follicle Stimulating Hormone. AMH: Anti-Mullerian Hormone
Characteristics of the IVF cycles in cases and in controls
| 0.89 | |||
| Protocol with GnRH agonists | 11 (14%) | 21 (14%) | |
| Protocol with GnRH antagonists | 65 (86%) | 131 (86%) | |
| 1983±867 | 2067±946 | 0.52 | |
| 9.1±1.8 | 9.1±1.8 | 1.00 | |
| 7.4±3.3 | 6.9±3.8 | 0.33 | |
| 0.69 | |||
| 1–4 | 17 (22%) | 42 (28%) | |
| 5–9 | 39 (51%) | 73 (48%) | |
| >9 | 20 (26%) | 37 (24%) | |
| 0.65 | |||
| Standard IVF | 47 (62%) | 99 (65%) | |
| ICSI | 25 (33%) | 42 (28%) | |
| Both | 4 (5%) | 11 (7%) | |
| 5 (4–8) | 5 (4–7) | 0.57 | |
| 74 (53–100) | 67 (50–83) | 0.40 | |
| 0.39 | |||
| Sequential | 59 (78%) | 110 (72%) | |
| Single | 17 (22%) | 42 (28%) | |
| 12 (16%) | 33 (22%) | 0.38 | |
| No viable embryos | 1 (1%) | 5 (3%) | 0.67 |
| Freeze-all | 11 (14%) | 28 (18%) | 0.58 |
| 0.56 | |||
| 1 | 24 (37%) | 43 (36%) | |
| 2 | 40 (63%) | 76 (64%) | |
| 0.16 | |||
| 0 | 4 (6%) | 19 (16%) | |
| 1 | 33 (52%) | 52 (44%) | |
| 2 | 27 (42%) | 48 (40%) | |
| Serum hCG positive | 22 (29%) | 40 (26%) | 0.67 |
| Clinical pregnancy | 21 (28%) | 35 (23%) | 0.45 |
| 0.10 | |||
| 0 | 50 (66%) | 78 (51%) | |
| 1–2 | 20 (26%) | 53 (25%) | |
| 3–5 | 6 (8%) | 21 (14%) | |
| 19 (25%) | 51 (34%) | 0.22 | |
| 29 (38%) | 53 (35%) | 0.63 | |
| Singletons | 26 (90%) | 46 (87%) | 1.00 |
| Twins | 3 (10%) | 7 (13%) | |
| 20 (69%) | 43 (79%) | 0.28 | |
| 33/126 (26%) | 60/247 (24%) | 0.71 | |
In the fresh cycle.
In one cycle a pregnancy was obtained both in the fresh (abortion) and in the frozen embryo transfer. Data is reported as mean±SD or number (%) or median (IQR). IVF: In Vitro Fertilization; hCG: Human Chorionic Gonadotropin
Summary of multiple regression analysis to predict the “Good Quality Index”
| 0.672 | 0.203 | |||
| 0.028 | 0.034 | 0.054 | 0.41 | |
| −0.010 | 0.005 | −0.151 | 0.07 | |
| 0.002 | 0.003 | 0.056 | 0.49 | |
| −0.023 | 0.006 | −0.244 | 0.001 | |
| 0.001 | 0.009 | 0.005 | 0.94 | |
| 0.001 | 0.000 | 0.126 | 0.06 | |
| −0.011 | 0.037 | −0.019 | 0.80 |
B= Unstandardized Regression Coefficient; SEB=Standard Error of the Coefficient; β= Standardized Coefficient